This study offers important insight into the pathogenic basis of intragenic frameshift deletions in the carboxy-terminal domain of MECP2, which account for some Rett syndrome cases, yet similar ...

There are already some add-on applets available in the COSMIC app store, such as both minimal and full-featured Start-menu ...

Members of the Windows 1.0 team at their 40-year reunion this week. L-R, kneeling/sitting: Joe Barello, Ed Mills, Tandy Trower, Mark Cliggett, Steve Ballmer (holding a Windows 1.0 screenshot) and Don ...

The ending is the main attraction of Tarkov 1.0, finally letting players experience the full story and make their way out of Tarkov in an exciting finale on a new map. Terminal is the final roadblock ...

Forbes contributors publish independent expert analyses and insights. Mike Stubbs covers esports, competitive games and the creator economy. Escape From Tarkov has officially launched with the 1.0 ...

Dominik Bošnjak is a freelance writer from Croatia. He has been writing about games for as long as he can remember and began doing so professionally circa 2010. If he was forced to pick a favorite ...

Things are about to get messy for free, over-the-air TV. This week, the Federal Communications Commission (FCC) passed a notice of proposed rulemaking that’s designed to allow broadcast TV stations to ...

As a diehard enthusiast of video games, Ediz Guner has been attentively following the ebbs and flows of the gaming industry for a long period of time. This, coupled with his hobby of extensively ...

Oral semaglutide at a dose of 25 mg may provide an alternative treatment option to injectable semaglutide (2.4 mg) and higher-dose oral semaglutide (50 mg) for persons with overweight or obesity. In a ...

GameSpot may get a commission from retail offers. Palworld developer Pocketpair has announced that the game will leave early access and launch its 1.0 version in 2026. Additionally, the studio teased ...

Orforglipron, a small-molecule, nonpeptide oral glucagon-like peptide-1 (GLP-1) receptor agonist, is being investigated as a treatment for obesity. In this phase 3, multinational, randomized, ...